IL158761A0 - Novel treatment for obsessive-compulsive disorders (ocd) and ocd-related disorders using gvg - Google Patents
Novel treatment for obsessive-compulsive disorders (ocd) and ocd-related disorders using gvgInfo
- Publication number
- IL158761A0 IL158761A0 IL15876102A IL15876102A IL158761A0 IL 158761 A0 IL158761 A0 IL 158761A0 IL 15876102 A IL15876102 A IL 15876102A IL 15876102 A IL15876102 A IL 15876102A IL 158761 A0 IL158761 A0 IL 158761A0
- Authority
- IL
- Israel
- Prior art keywords
- ocd
- disorders
- gvg
- obsessive
- novel treatment
- Prior art date
Links
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/853,392 US6462084B1 (en) | 2001-05-14 | 2001-05-14 | Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG |
PCT/US2002/014344 WO2002092071A1 (fr) | 2001-05-14 | 2002-05-08 | Nouveau traitement d'un trouble obsessionnel-compulsif (ocd) et de troubles associes aux ocd faisant appel au gvg |
Publications (1)
Publication Number | Publication Date |
---|---|
IL158761A0 true IL158761A0 (en) | 2004-05-12 |
Family
ID=25315916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15876102A IL158761A0 (en) | 2001-05-14 | 2002-05-08 | Novel treatment for obsessive-compulsive disorders (ocd) and ocd-related disorders using gvg |
Country Status (18)
Country | Link |
---|---|
US (2) | US6462084B1 (fr) |
EP (1) | EP1392273A4 (fr) |
JP (1) | JP2004533445A (fr) |
KR (1) | KR20040028758A (fr) |
CN (1) | CN1509168A (fr) |
BR (1) | BR0209614A (fr) |
CA (1) | CA2446641A1 (fr) |
CZ (1) | CZ20033379A3 (fr) |
HR (1) | HRP20030894A2 (fr) |
HU (1) | HUP0400032A3 (fr) |
IL (1) | IL158761A0 (fr) |
MX (1) | MXPA03010406A (fr) |
NO (1) | NO20035037L (fr) |
NZ (1) | NZ529613A (fr) |
PL (1) | PL367362A1 (fr) |
TW (1) | TWI313599B (fr) |
WO (1) | WO2002092071A1 (fr) |
YU (1) | YU89103A (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002043731A2 (fr) | 2000-11-30 | 2002-06-06 | University Of Florida | Traitements de troubles neurogenetiques, de troubles du controle des impulsions, et cicatrisation des lesions |
CA2488566A1 (fr) * | 2002-06-27 | 2004-01-08 | Warner-Lambert Company Llc | Methode de traitement du trouble d'hyperactivite avec deficit de l'attention |
EP1617862B1 (fr) * | 2003-04-25 | 2012-12-05 | Allergan, Inc. | Neurotoxine botulique pour le traitment des symptomes de comportements compulsifs obsedants |
US7393537B2 (en) | 2003-04-25 | 2008-07-01 | Allergan, Inc. | Botulinum toxin for treatment of obsessive compulsive finger biting disorder |
US20110275664A1 (en) * | 2005-09-26 | 2011-11-10 | The Regents Of The University Of Colorado,A Body Corporate | Method for treating drug and behavioral addictions |
GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
US8969413B2 (en) * | 2010-02-25 | 2015-03-03 | Catalyst Pharmaceutical Partners | Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid |
US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
US20130143867A1 (en) | 2011-12-02 | 2013-06-06 | Sychroneuron Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
WO2014197744A1 (fr) * | 2013-06-05 | 2014-12-11 | Synchroneuron, Inc. | Formulations d'acamprosate, procédés d'utilisation de celles-ci, et combinaisons comprenant celles-ci |
CN104306736A (zh) * | 2014-10-31 | 2015-01-28 | 哈尔滨市海江科技开发有限公司 | 一种治疗疑病症的膏药及其制备方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4761429A (en) | 1985-07-22 | 1988-08-02 | Kenneth Blum | Enkephalinase and endorphinase inhibitors as anti-craving compositions |
US5189064A (en) | 1985-07-22 | 1993-02-23 | Matrix Technologies, Inc. | Treatment of ***e addiction |
US4786647A (en) | 1986-06-30 | 1988-11-22 | University Of Florida | Method for eliciting anxiolysis |
US4980168A (en) | 1989-10-13 | 1990-12-25 | Natrol, Inc. | Dietary supplement for children |
EP0767174A1 (fr) | 1991-11-21 | 1997-04-09 | Ciba-Geigy Ag | Nouveaux acides aminalcanephosphiniques et leurs sels |
HU222339B1 (hu) * | 1992-05-20 | 2003-06-28 | Northwestern University | S-(+)-4-amino-3-(2-metil-propil)-butánsav, és gyógyászati szempontból elfogadható sói, ezeket tartalmazó gyógyászati készítmények, valamint az (S)-(+)-4-amino-3-(2-metil-propil)-butánsav előállítása |
US5792796A (en) * | 1994-07-27 | 1998-08-11 | Warner-Lambert Company | Methods for treating anxiety and panic |
US6071537A (en) | 1996-06-28 | 2000-06-06 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating obesity |
US5776956A (en) | 1996-07-30 | 1998-07-07 | Lectec Corporation | Use of cotinine in treating psychiatric disorders |
US6117855A (en) * | 1996-10-07 | 2000-09-12 | Merck Sharp & Dohme Ltd. | Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
EP1043980A2 (fr) | 1997-10-28 | 2000-10-18 | Schering Corporation | Procede de reduction de l'appetence chez les mammiferes |
US6391922B1 (en) * | 1998-01-13 | 2002-05-21 | Synchroneuron, Llc | Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders |
US6541520B1 (en) * | 1998-08-05 | 2003-04-01 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
WO2000023059A2 (fr) * | 1998-10-20 | 2000-04-27 | Ortho-Mcneil Pharmaceutical, Inc. | Derives anticonvulsifs utiles dans les traitements de dependance, d'accoutumance et d'abus d'alcool |
CN1196482C (zh) | 1999-02-01 | 2005-04-13 | 奥索-麦克尼尔药品公司 | 抗惊厥药衍生物在治疗神经性食欲过盛症中的应用 |
CZ20013061A3 (cs) | 1999-02-24 | 2002-06-12 | University Of Cincinnati | Pouľití sulfamátových derivátů pro léčbu poruch kontroly impulsů |
JP2003530300A (ja) | 1999-04-08 | 2003-10-14 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 体重低下を維持することに有用な抗痙攣薬誘導体 |
WO2002043731A2 (fr) * | 2000-11-30 | 2002-06-06 | University Of Florida | Traitements de troubles neurogenetiques, de troubles du controle des impulsions, et cicatrisation des lesions |
-
2001
- 2001-05-14 US US09/853,392 patent/US6462084B1/en not_active Expired - Fee Related
-
2002
- 2002-05-08 EP EP02729142A patent/EP1392273A4/fr not_active Withdrawn
- 2002-05-08 JP JP2002588988A patent/JP2004533445A/ja active Pending
- 2002-05-08 BR BR0209614-5A patent/BR0209614A/pt not_active IP Right Cessation
- 2002-05-08 IL IL15876102A patent/IL158761A0/xx unknown
- 2002-05-08 KR KR10-2003-7014792A patent/KR20040028758A/ko not_active Application Discontinuation
- 2002-05-08 CZ CZ20033379A patent/CZ20033379A3/cs unknown
- 2002-05-08 MX MXPA03010406A patent/MXPA03010406A/es active IP Right Grant
- 2002-05-08 YU YU89103A patent/YU89103A/sh unknown
- 2002-05-08 HU HU0400032A patent/HUP0400032A3/hu unknown
- 2002-05-08 WO PCT/US2002/014344 patent/WO2002092071A1/fr active IP Right Grant
- 2002-05-08 CN CNA028098269A patent/CN1509168A/zh active Pending
- 2002-05-08 PL PL02367362A patent/PL367362A1/xx not_active Application Discontinuation
- 2002-05-08 CA CA002446641A patent/CA2446641A1/fr not_active Abandoned
- 2002-05-08 NZ NZ529613A patent/NZ529613A/en unknown
- 2002-05-13 TW TW091109922A patent/TWI313599B/zh not_active IP Right Cessation
- 2002-06-20 US US10/175,576 patent/US20020169103A1/en not_active Abandoned
-
2003
- 2003-11-05 HR HR20030894A patent/HRP20030894A2/hr not_active Application Discontinuation
- 2003-11-13 NO NO20035037A patent/NO20035037L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1509168A (zh) | 2004-06-30 |
US20020169103A1 (en) | 2002-11-14 |
HRP20030894A2 (en) | 2004-06-30 |
CA2446641A1 (fr) | 2002-11-21 |
US6462084B1 (en) | 2002-10-08 |
PL367362A1 (en) | 2005-02-21 |
HUP0400032A2 (hu) | 2004-04-28 |
HUP0400032A3 (en) | 2012-09-28 |
JP2004533445A (ja) | 2004-11-04 |
YU89103A (sh) | 2006-08-17 |
KR20040028758A (ko) | 2004-04-03 |
MXPA03010406A (es) | 2004-05-05 |
WO2002092071A1 (fr) | 2002-11-21 |
NO20035037L (no) | 2004-01-07 |
EP1392273A1 (fr) | 2004-03-03 |
NZ529613A (en) | 2006-09-29 |
EP1392273A4 (fr) | 2004-11-24 |
NO20035037D0 (no) | 2003-11-13 |
TWI313599B (en) | 2009-08-21 |
CZ20033379A3 (cs) | 2004-12-15 |
BR0209614A (pt) | 2004-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0112343D0 (en) | Well treatment | |
AU2002358934A1 (en) | Pelvic disorder treatment device | |
GB0129976D0 (en) | Treatment method | |
IL158761A0 (en) | Novel treatment for obsessive-compulsive disorders (ocd) and ocd-related disorders using gvg | |
EP1422743A4 (fr) | Systeme de traitement | |
AU2002236781A1 (en) | Treatment for snoring | |
GB0120147D0 (en) | Treatment method | |
GB0319239D0 (en) | Process and apparatus | |
GB0105899D0 (en) | Fibrosis reduction treatment | |
GB0127384D0 (en) | Well treatment system | |
GB0130763D0 (en) | Treatment methods | |
GB0103031D0 (en) | Novel treatment | |
GB2376239B (en) | Cask treatment | |
GB0126253D0 (en) | Treatment method | |
AU2002101010A4 (en) | Treatment process and apparatus | |
HK1049477A1 (en) | Apparatus for beauty treatment. | |
GB0130694D0 (en) | Treatment | |
GB2413797B (en) | Microorganisms for well treatment | |
GB0110191D0 (en) | Sterilization method | |
GB0102927D0 (en) | Treatment method | |
AU2002229796A1 (en) | Method for treating sleep disorders | |
GB0116837D0 (en) | Treatment | |
GB0109519D0 (en) | Nimico treatment | |
GB0117425D0 (en) | Novel treatment | |
GB0117419D0 (en) | Novel treatment |